Repligen completes patient treatment in phase III RG-1068/MRI imaging trial Oct. 21, 2009 No Comments
Epigenomics launches Epi proColon diagnostic blood test for colorectal cancer in Europe Oct. 20, 2009 No Comments
TcLand Expression starts study of K-RejX test in kidney transplant recipients at risk of CAMR Oct. 20, 2009 No Comments
Transgenomic licenses Cold-PCR technology from Dana-Farber Cancer Institute Oct. 20, 2009 No Comments
FDA authorizes Diatherix Laboratories' H1N1-09 influenza test for emergency use Oct. 20, 2009 No Comments
Re-engineered ABY-025 shows specific HER2 binding, favorable biodistribution Oct. 14, 2009 No Comments